Career Development Program

职业发展计划

• 批准号: 8588560
• 负责人: Lawrence S Kirschner
• 金额: $ 8.83万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-25 至 2018-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8588560
• 关键词: Academia; Area; Attention; Cancer Center; Development; Diagnosis; Discipline; Disease; Distant; Eligibility Determination; Environment; Epidemiology; Etiology; Faculty; Funding; Future; Grant; Incidence; Individual; Instruction; Leadership; Malignant Neoplasms; Malignant neoplasm of thyroid; Mentors; Mentorship; Minority; Ohio; Patients; Peer Review; Positioning Attribute; Postdoctoral Fellow; Prevention; Process; Qualifying; Recommendation; Research; Research Personnel; Resources; Science; Scientist; Talents; Training; Translational Research; Universities; Woman; anticancer research; base; career; career development; clinical practice; member; novel strategies; programs; stem; success

The development of translational researchers in thyroid cancer requires a diligent commitment to the identification of talented researchers at the junior level, and the placement pf these individuals into a supportive environment which provides not only significant expertise in thyroid cancer, but also the provision for mentorship. Another way to produce leaders in the field of thyroid cancer research is to encourage successful translational scientists to re-focus their talents from other areas into this area. The Career Development Program (CDP) of this thyroid cancer SPORE is an essential component of the application because it provides the mechanism to encourage excellent junior scientists to establish careers in this field and to attract the expertise of established researchers from other disciplines. For this thyroid cancer-focused application, the combination of resources (both patient and research resources) and guidance present at The Ohio State University (OSU) and at the MD Anderson Gancer Center (MDACC) provides an unparalleled environment to enable these new and junior investigators to succeed as independent researchers and to develop future careers which will contribute to progress in stemming the rising incidence of this malignancy and develop new therapies for those with local and distant metastatic disease. To this end, the CDP will fund promising young investigators or, in certain circumstances, more senior faculty reorienting from clinical practice or another field for 2 years at $50,000 per year. Special attention will be paid to the recruitment of applicants from diverse backgrounds. Applications will be solicited from all departments and centers at OSU and MDACC. They will be screened for eligibility by CDP Leadership to assure adequate representation from qualified women and minorities. Applications will be judged based on the potential of the candidate, the strength of the proposed research and the appropriateness of the mentor. Applications will be scored and ranked by members of the CDP Committee and final funding recommendations made to the SPORE Steering Committee. Each position will be funded for one year, with a second year dependent upon satisfactory progress. Over the course of the grant, the SPORE will provide 44.6% of the funding for the CPD, which will be matched by 38.1%, and 17.3% provided from OSUCCC and MDACC, respectively. Success of the program will be judged by the quality of the science generated by the awardees, their success in obtaining external peer-reviewed funding, their success in academic advancement, and their retention in academia and translational research in thyroid cancer. RELEVANCE (See instructions): The Career Development Program (CDP) is an important component of this thyroid cancer SPORE application and the national SPORE program because it will assure a cadre of academic faculty who are specially trained translational scientists and clinicians dedicated to discover and apply new approaches to understanding the etiology and epidemiology, prevention, diagnosis, treatment and cure of patients with thyroid cancer.

甲状腺癌转化研究人员的发展需要对 在初中识别才华横溢的研究人员，并将这些人安置在 支持环境不仅提供甲状腺癌的重要专业知识，而且还提供了规定 进行指导。在甲状腺癌研究领域培养领导者的另一种方法是鼓励 成功的翻译科学家将他们的才能从其他领域重新聚焦到该领域。职业 该甲状腺癌孢子的开发计划（CDP）是应用的重要组成部分 因为它提供了鼓励优秀的初级科学家在这一领域建立职业的机制 并吸引来自其他学科的知名研究人员的专业知识。为此以甲状腺癌为中心 应用，资源的组合（患者和研究资源）以及在 俄亥俄州立大学（OSU）和MD Anderson Gancer中心（MDACC）提供了无与伦比的 环境使这些新的和初级调查人员能够成功成为独立研究人员，并 发展未来的职业，这将有助于阻止这种恶性肿瘤的发生率上升 并为患有局部和遥远转移性疾病的人开发新疗法。 为此，CDP将资助有前途的年轻调查员，或者在某些情况下，更多的高级 教师从临床实践或其他领域重新定位2年，每年50,000美元。特别关注 付给来自不同背景的申请人的招募。申请将得到所有人的要求 OSU和MDACC的部门和中心。他们将筛选CDP领导才能资格 确保合格妇女和少数民族的足够代表。申请将根据 候选人的潜力，拟议的研究的优势和导师的适当性。 申请将由CDP委员会成员和最终资金评分和排名 向孢子指导委员会提出的建议。每个职位将资助一年， 第二年取决于令人满意的进度。在赠款的过程中，孢子将提供 CPD资金的44.6％，将匹配38.1％，OSUCCC和17.3％的资金和17.3％ MDACC分别。该计划的成功将以由 获奖者，他们在获得外部同行评审资金方面的成功，他们在学术方面的成功 进步及其在甲状腺癌中的学术界和转化研究中的保留。 相关性（请参阅说明）： 职业发展计划（CDP）是这种甲状腺癌的重要组成部分 申请和国家孢子计划，因为它将确保一群学术教师的干部 专门培训的翻译科学家和临床医生致力于发现和采用新方法 了解患者的病因学和流行病学，预防，诊断，治疗和治疗 甲状腺癌。